Back to 
Jefferies Financial Group Inc.
Jefferies Financial Group Inc.
KYMR
Showing 1 of 7 quarters
Position history for Jefferies Financial Group Inc.'s holdings in Kymera Therapeutics, Inc.
No. Jefferies Financial Group exited its KYMR (Kymera Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 19,200 shares worth $573,120. Jefferies Financial Group first reported KYMR in Q1 2023 and held it in 5 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History